Atorvastatin, ,

Phase 1Small molecule

SShaheed Benazir Bhutto University Sheringal Dir Upper

Atorvastatin, , is one of 16 small molecule programs targeting Cardiovascular. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

CardiovascularNot yet recruiting

StatinsNot yet recruiting

CardiovascularPhase 1

Not yet recruiting

StatinsPhase 1

Not yet recruiting

Competition

Competitive Landscape

17 competitors in Cardiovascular

#DrugCompanyPhaseTrials

Crestor

AstraZeneca

Approved

5 2

Ozempic

Novo Nordisk

Approved

3 3

Bayer Aspirin

Bayer

Approved

2 4

Cialis

Eli Lilly

Phase 3

1 5

Letairis

Gilead

Phase 3

1 6

Lipitor

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

3 7

Metformin XR

AstraZeneca

Phase 3

1 8

Xarelto

WWim Janssens

Phase 1

1 9

Dapansutrile

OOlatec Therapeutics LLC

Phase 1

1 10

Statins

Sanofi

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Phase 1Not yet recruiting

Statins

NCT07378293

Phase 1Not yet recruiting

Cardiovascular

NCT07389304

Clinical

Trials by Indication[1]

Long COVID-191 trial

Investigating Measurable PRO Acuity Trial (IMPACT) is a Multi-Center Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Maraviroc and Atorvastatin to Improve Neurocognitive and Physical Function of Subjects With Long COVID-19/Post-Acute Sequelae of COVID-19 (PASC).

Not yet recruiting·HHealthBio, Inc.·Phase 2/3·NCT06974084·252 enrolled

Statins1 trial

Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers

Not yet recruiting·SShaheed Benazir Bhutto University Sheringal Dir Upper·Phase 1·NCT07378293·100 enrolled

Cardiovascular1 trial

[Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]

Not yet recruiting·SShaheed Benazir Bhutto University Sheringal Dir Upper·Phase 1·NCT07389304·100 enrolled

Unspecified1 trial

Korean AMADEUS Study

Unknown status·TThe Catholic University of Korea·Phase 4·NCT01239849·500 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Atorvastatin, ,. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Atorvastatin, , compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Atorvastatin, ,. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Shaheed Benazir Bhutto University Sheringal Dir Upper company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: SShaheed Benazir Bhutto University Sheringal Dir Upper

Atorvastatin, ,

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Trials by Indication[1]

Long COVID-191 trial

Statins1 trial

Cardiovascular1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News